Gene-sequencing machine maker Illumina Inc has filed an appeal against an order from the U.S. Federal Trade Commission (FTC) that demands it divest cancer diagnostic test maker Grail Inc due to competition concerns.
Illumina spun off Grail in 2016 but retained a 12% stake. It reacquired Grail in 2021 despite opposition from European and U.S. regulators.Sources: Company statements, Reuters reportsOur Standards:.
Illumina spun off Grail in 2016 but retained a 12% stake. It reacquired Grail in 2021 despite opposition from European and U.S. regulators.Sources: Company statements, Reuters reportsOur Standards:Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Illumina CEO resigns following push by activist investor Carl Icahn to remove himResignation follows shareholder discontent around Illumina's acquisition of cancer diagnostic startup Grail
Baca lebih lajut »
Illumina announces CEO transition plan as Francis deSouza resignsIllumina announced its board of directors has accepted the resignation of CEO Francis deSouza Sunday.
Baca lebih lajut »
Illumina CEO Francis DeSouza resigns after battle with IcahnIllumina Chief Executive Officer Francis DeSouza stepped down on Sunday, the gene-sequencing machine maker said in a statement, ending a battle with activist investor Carl Icahn in which the company's chairman left the company earlier this year.
Baca lebih lajut »
Marvel To Launch Avengers Inc, From Al Ewing & Leonard KirkWe've had a Batman Inc. We've had a Joker Inc. Now, we have Avengers, Inc. But looking a bit more like the British TV show...
Baca lebih lajut »
Thanks to this North Texas company, It's payday for student athletes - CEO SpotlightBrent Chapman, CEO of myNILpay, Inc. joins David Johnson on this episode of CEO Spotlight.
Baca lebih lajut »